Haoyu Zhang
Key Laboratory Of Structure Based Drug Design And Discovery, 103 Wenhua Road, Shenhe District
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Design, Synthesis, and Biological Activity Evaluation of Quinazoline-Based PLK4 Inhibitors.
Journal: Biomedicines
Published: June 08, 2026
Discovery of highly selective and potent CYP1B1 inhibitors for overcoming paclitaxel resistance in A549/Taxol cells.
Journal: European journal of medicinal chemistry
Published: May 19, 2026
Discovery of Highly Selective CYP1B1 Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 16, 2025
Design, Synthesis, and Biological Activity Evaluation of Deuterated Diphenyl Azole Alcohol-Based CYP51 Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 03, 2025
Design, synthesis, and activity evaluation of novel tetrazole-based CYP51 inhibitors.
Journal: Bioorganic chemistry
Published: May 09, 2025
Rational design of CZL-S092: A novel indazole-based PLK4 inhibitor targeting neuroblastoma through virtual screening and fragment-based drug design strategies.
Journal: European journal of medicinal chemistry
Published: April 27, 2025
Discovery of highly potent triazole derivatives with broad-spectrum antifungal activity based on Iodiconazole.
Journal: European journal of medicinal chemistry
Published: July 24, 2024
Design, synthesis and bioactivity evaluation of triazole antifungal drugs with phenylthiophene structure.
Journal: Bioorganic chemistry
Published: June 25, 2024
Insights into the selective mechanism of PDE2/9a inhibitors from silico aspects.
Journal: Journal of biomolecular structure & dynamics
Published: March 25, 2024
Discovery of non-sulfonamide carbonic anhydrase IX inhibitors through structure-based virtual screening.
Journal: Physical chemistry chemical physics : PCCP
Published: February 29, 2024
Last Updated: 09/26/2026